Lifestyle interventions in the management of systemic sclerosis: a systematic review of the literature

I Parodis, A Tsoi, A Gomez, JW Chow… - … Advances in Practice, 2024 - academic.oup.com
Objectives We aimed to investigate the efficacy of lifestyle interventions for the management
of systemic sclerosis (SSc). Methods We searched the databases Medline, Embase, Web of …

Prevalence and characteristics of, and knowledge related to, photosensitivity in patients with lupus erythematosus: the international PHOTOLUP study

G Battesti, R Felten, M Piga… - …, 2023 - academic.oup.com
Objective The objective of this study was to assess the prevalence and characteristics of,
and knowledge about, photosensitivity and the use of photoprotective measures in an …

Factors Associated With Distress Related to Perceived Dignity in Patients With Rheumatic Diseases

V Pascual-Ramos, I Contreras-Yáñez… - JCR: Journal of …, 2024 - journals.lww.com
Background The loss of perceived dignity is an existential source of human suffering,
described in patients with cancer and chronic diseases and hospitalized patients but rarely …

Higher mortality risk from gynaecological neoplasms and non-Hodgkin's lymphoma in patients with systemic lupus erythematosus: an observational study from the …

V Moreno-Torres, M Martínez-Urbistondo… - Lupus Science & …, 2024 - lupus.bmj.com
Objective To evaluate the impact of the different types of neoplasms and lineages on
mortality of patients with SLE. Methods Retrospective and observational comparison of the …

In the Pursuit of Precision: Novel Target Therapies Revolutionizing SLE Care

T Velikova, D Miteva, M Kokudeva, GH Vasilev… - Rheumato, 2024 - mdpi.com
Systemic lupus erythematosus (SLE) is a chronic, autoimmune, immune complex-mediated
disease affecting mainly females at a young age. The disease etiology is still unknown, and …

Clinical trial outcomes for SLE: what we have and what we need

L Arnaud, I Parodis, H Devilliers… - Lupus Science & …, 2024 - lupus.bmj.com
The paradigm of drug approval in SLE currently relies on successful large phase III
randomised controlled trials and a set of primary, secondary and additional end points …

P150 Temporal trends in treatment patterns in systemic lupus erythematosus in Sweden

A Dominicus, A Mageau, NV Nguyen, E Svenungsson… - 2024 - lupus.bmj.com
Objective It is unknown how patients with SLE are treated in real-life settings in European
countries and to what extent treatment recommendations regarding the prescription of …

[PDF][PDF] IMPORTANT SAFETY INFORMATION CONTRAINDICATION

A Fanouriakis, M Kostopoulou, J Andersen - 2023 - sleguidelines.com
Objectives To update the EULAR recommendations for the management of systemic lupus
erythematosus (SLE) based on emerging new evidence. Methods An international Task …

A COYOTE-INSPIRED APPROACH FOR SYSTEMIC LUPUS ERYTHEMATOSUS PREDICTION USING NEURAL NETWORKS

S Mummaneni, P Dodda, ND Ginjupalli - … , Automatyka, Pomiary w …, 2024 - ph.pollub.pl
Abstract Systemic Lupus Erythematosus (SLE) is a complicated autoimmune disease that
can present with a variety of clinical symptoms, making precise prognosis difficult. Because …

[PDF][PDF] Lessons learnt from the recent recommendations for the non-pharmacological management of systemic sclerosis

T Santiago, R Fernandes, R Ferreira… - ARP …, 2024 - arprheumatology.com
Dear Editor, In inflammatory rheumatic diseases including systemic sclerosis (SSc) there is
growing evidence that treatment strategies should not only target disease control in terms of …